PHILLIP MD ET AL FROST Insider Trading $PLX Protalix BioTherapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PHILLIP MD ET AL FROST.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PHILLIP MD ET AL FROST. PHILLIP MD ET AL FROST is 10% Owner in NON INVASIVE MONITORING SYSTEMS INC /FL/ ($NIMU) and CEO & Chairman in Opko Health, Inc. ($EXEG) and 10% Owner in Protalix BioTherapeutics, Inc. ($PLX) and Director in Protalix BioTherapeutics, Inc. ($PLX) and 10% Owner in Tiger X Medical, Inc. ($CLIK) and Director in PROLOR Biotech, Inc. ($PBTH).
PHILLIP MD ET AL FROST in Protalix BioTherapeutics, Inc.
Trading Symbol: PLXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PHILLIP MD ET AL FROST: 10% Owner, Director
Holdings: 7,788,241 shares
Current Value: $6,152,710
Latest Transaction: Sep 11 2009
$PLX Market Capitalization: $78.10M
$PLX Previous Close: $0.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PHILLIP MD ET AL FROST in Protalix BioTherapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BCDA, NIMU, EXEG, PBTH, PLX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.25 | 5,000 | 36,250 | 7,788,241 | 7.8 M to 7.8 M (-0.06 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.20 | 3,581 | 25,783 | 7,793,241 | 7.8 M to 7.8 M (-0.05 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.18 | 6,419 | 46,088 | 7,796,822 | 7.8 M to 7.8 M (-0.08 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.16 | 200 | 1,432 | 7,803,241 | 7.8 M to 7.8 M (0.00 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.15 | 700 | 5,005 | 7,803,441 | 7.8 M to 7.8 M (-0.01 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.14 | 4,689 | 33,479 | 7,804,141 | 7.8 M to 7.8 M (-0.06 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.12 | 600 | 4,272 | 7,808,830 | 7.8 M to 7.8 M (-0.01 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.11 | 1,801 | 12,805 | 7,809,430 | 7.8 M to 7.8 M (-0.02 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.10 | 1,300 | 9,230 | 7,811,231 | 7.8 M to 7.8 M (-0.02 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.09 | 330 | 2,340 | 7,812,531 | 7.8 M to 7.8 M (0.00 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.06 | 380 | 2,683 | 7,812,861 | 7.8 M to 7.8 M (0.00 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.89 | 2,500 | 17,225 | 7,813,241 | 7.8 M to 7.8 M (-0.03 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.85 | 2,500 | 17,125 | 7,815,741 | 7.8 M to 7.8 M (-0.03 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.80 | 15,000 | 102,000 | 7,818,241 | 7.8 M to 7.8 M (-0.19 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.79 | 2,200 | 14,938 | 7,833,241 | 7.8 M to 7.8 M (-0.03 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.78 | 2,800 | 18,984 | 7,835,441 | 7.8 M to 7.8 M (-0.04 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.71 | 10,000 | 67,100 | 7,838,241 | 7.8 M to 7.8 M (-0.13 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.68 | 5,000 | 33,400 | 7,848,241 | 7.9 M to 7.8 M (-0.06 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.67 | 810 | 5,403 | 7,853,241 | 7.9 M to 7.9 M (-0.01 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.66 | 5,190 | 34,565 | 7,854,051 | 7.9 M to 7.9 M (-0.07 %) |
Sep 03 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.64 | 4,000 | 26,560 | 7,859,241 | 7.9 M to 7.9 M (-0.05 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.55 | 974 | 7,354 | 7,610,167 | 7.6 M to 7.6 M (-0.01 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.54 | 2,300 | 17,342 | 7,611,141 | 7.6 M to 7.6 M (-0.03 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.53 | 1,700 | 12,801 | 7,613,441 | 7.6 M to 7.6 M (-0.02 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.52 | 1,100 | 8,272 | 7,615,141 | 7.6 M to 7.6 M (-0.01 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.51 | 750 | 5,633 | 7,616,241 | 7.6 M to 7.6 M (-0.01 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.50 | 12,300 | 92,250 | 7,616,991 | 7.6 M to 7.6 M (-0.16 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.48 | 3,716 | 27,796 | 7,629,291 | 7.6 M to 7.6 M (-0.05 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.47 | 3,200 | 23,904 | 7,633,007 | 7.6 M to 7.6 M (-0.04 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.45 | 1,800 | 13,410 | 7,636,207 | 7.6 M to 7.6 M (-0.02 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.44 | 50,900 | 378,696 | 7,638,007 | 7.7 M to 7.6 M (-0.66 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.43 | 5,596 | 41,578 | 7,688,907 | 7.7 M to 7.7 M (-0.07 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.42 | 1,400 | 10,388 | 7,694,503 | 7.7 M to 7.7 M (-0.02 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.41 | 8,284 | 61,384 | 7,695,903 | 7.7 M to 7.7 M (-0.11 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.40 | 13,200 | 97,680 | 7,704,187 | 7.7 M to 7.7 M (-0.17 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.39 | 1,600 | 11,824 | 7,717,387 | 7.7 M to 7.7 M (-0.02 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.38 | 9,254 | 68,295 | 7,718,987 | 7.7 M to 7.7 M (-0.12 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.37 | 4,179 | 30,799 | 7,728,241 | 7.7 M to 7.7 M (-0.05 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.35 | 5,821 | 42,784 | 7,732,420 | 7.7 M to 7.7 M (-0.08 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.62 | 1,216 | 9,266 | 7,738,241 | 7.7 M to 7.7 M (-0.02 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.61 | 6,918 | 52,646 | 7,739,457 | 7.7 M to 7.7 M (-0.09 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.60 | 912 | 6,931 | 7,746,375 | 7.7 M to 7.7 M (-0.01 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.59 | 300 | 2,277 | 7,747,287 | 7.7 M to 7.7 M (0.00 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.58 | 4,728 | 35,838 | 7,747,587 | 7.8 M to 7.7 M (-0.06 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.57 | 5,650 | 42,771 | 7,752,315 | 7.8 M to 7.8 M (-0.07 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.56 | 100 | 756 | 7,757,965 | 7.8 M to 7.8 M (0.00 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.55 | 400 | 3,020 | 7,758,065 | 7.8 M to 7.8 M (-0.01 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.54 | 2,500 | 18,850 | 7,758,465 | 7.8 M to 7.8 M (-0.03 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.53 | 3,845 | 28,953 | 7,760,965 | 7.8 M to 7.8 M (-0.05 %) |
Sep 11 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 7.52 | 23,431 | 176,201 | 7,764,810 | 7.8 M to 7.8 M (-0.30 %) |
Aug 28 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.02 | 408 | 2,456 | 7,863,241 | 7.9 M to 7.9 M (-0.01 %) |
Aug 28 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.01 | 950 | 5,710 | 7,863,649 | 7.9 M to 7.9 M (-0.01 %) |
Aug 28 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.00 | 25,949 | 155,694 | 7,864,599 | 7.9 M to 7.9 M (-0.33 %) |
Aug 28 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.07 | 175 | 1,062 | 7,890,548 | 7.9 M to 7.9 M (0.00 %) |
Aug 28 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.06 | 550 | 3,333 | 7,890,723 | 7.9 M to 7.9 M (-0.01 %) |
Aug 28 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.05 | 1,050 | 6,353 | 7,891,273 | 7.9 M to 7.9 M (-0.01 %) |
Aug 28 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.04 | 2,900 | 17,516 | 7,892,323 | 7.9 M to 7.9 M (-0.04 %) |
Aug 28 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.03 | 7,094 | 42,777 | 7,895,223 | 7.9 M to 7.9 M (-0.09 %) |
Aug 28 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.02 | 5,009 | 30,154 | 7,902,317 | 7.9 M to 7.9 M (-0.06 %) |
Aug 28 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.01 | 7,222 | 43,404 | 7,907,326 | 7.9 M to 7.9 M (-0.09 %) |
Aug 28 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.00 | 16,000 | 96,000 | 7,914,548 | 7.9 M to 7.9 M (-0.20 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.35 | 3,000 | 19,050 | 7,985,048 | 8 M to 8 M (-0.04 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.32 | 3,116 | 19,693 | 7,988,048 | 8 M to 8 M (-0.04 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.30 | 30,649 | 193,089 | 7,991,164 | 8 M to 8 M (-0.38 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.10 | 8,396 | 51,216 | 8,021,813 | 8 M to 8 M (-0.10 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.09 | 4,004 | 24,384 | 8,030,209 | 8 M to 8 M (-0.05 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.08 | 23,509 | 142,935 | 8,034,213 | 8.1 M to 8 M (-0.29 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.07 | 20,341 | 123,470 | 8,057,722 | 8.1 M to 8.1 M (-0.25 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.06 | 23,587 | 142,937 | 8,078,063 | 8.1 M to 8.1 M (-0.29 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.05 | 52,994 | 320,614 | 8,101,650 | 8.2 M to 8.1 M (-0.65 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.04 | 44,140 | 266,606 | 8,154,644 | 8.2 M to 8.2 M (-0.54 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.03 | 41,982 | 253,151 | 8,198,784 | 8.2 M to 8.2 M (-0.51 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.02 | 29,488 | 177,518 | 8,240,766 | 8.3 M to 8.2 M (-0.36 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.01 | 27,399 | 164,668 | 8,270,254 | 8.3 M to 8.3 M (-0.33 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.00 | 70,895 | 425,370 | 8,297,653 | 8.4 M to 8.3 M (-0.85 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.20 | 6,300 | 39,060 | 8,368,548 | 8.4 M to 8.4 M (-0.08 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.19 | 1,700 | 10,523 | 8,374,848 | 8.4 M to 8.4 M (-0.02 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.17 | 10,000 | 61,700 | 8,376,548 | 8.4 M to 8.4 M (-0.12 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.14 | 1,000 | 6,140 | 8,386,548 | 8.4 M to 8.4 M (-0.01 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.13 | 6,299 | 38,613 | 8,387,548 | 8.4 M to 8.4 M (-0.08 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.12 | 600 | 3,672 | 8,393,847 | 8.4 M to 8.4 M (-0.01 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.11 | 100 | 611 | 8,394,447 | 8.4 M to 8.4 M (0.00 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.10 | 6,177 | 37,680 | 8,394,547 | 8.4 M to 8.4 M (-0.07 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.09 | 4,300 | 26,187 | 8,400,724 | 8.4 M to 8.4 M (-0.05 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.06 | 1,800 | 10,908 | 8,405,024 | 8.4 M to 8.4 M (-0.02 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.05 | 44,683 | 270,332 | 8,406,824 | 8.5 M to 8.4 M (-0.53 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.04 | 18,141 | 109,572 | 8,451,507 | 8.5 M to 8.5 M (-0.21 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.03 | 3,050 | 18,392 | 8,469,648 | 8.5 M to 8.5 M (-0.04 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.02 | 5,959 | 35,873 | 8,472,698 | 8.5 M to 8.5 M (-0.07 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.01 | 3,400 | 20,434 | 8,478,657 | 8.5 M to 8.5 M (-0.04 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.00 | 34,856 | 209,136 | 8,482,057 | 8.5 M to 8.5 M (-0.41 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.22 | 1,202 | 7,476 | 7,930,548 | 7.9 M to 7.9 M (-0.02 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.20 | 1,467 | 9,095 | 7,931,750 | 7.9 M to 7.9 M (-0.02 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.18 | 873 | 5,395 | 7,933,217 | 7.9 M to 7.9 M (-0.01 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.17 | 1,405 | 8,669 | 7,934,090 | 7.9 M to 7.9 M (-0.02 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.16 | 134 | 825 | 7,935,495 | 7.9 M to 7.9 M (0.00 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.15 | 3,480 | 21,402 | 7,935,629 | 7.9 M to 7.9 M (-0.04 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.14 | 1,962 | 12,047 | 7,939,109 | 7.9 M to 7.9 M (-0.02 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.13 | 3,010 | 18,451 | 7,941,071 | 7.9 M to 7.9 M (-0.04 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.12 | 134 | 820 | 7,944,081 | 7.9 M to 7.9 M (0.00 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.11 | 1,381 | 8,438 | 7,944,215 | 7.9 M to 7.9 M (-0.02 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.10 | 735 | 4,484 | 7,945,596 | 7.9 M to 7.9 M (-0.01 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.09 | 1,331 | 8,106 | 7,946,331 | 7.9 M to 7.9 M (-0.02 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.08 | 2,304 | 14,008 | 7,947,662 | 7.9 M to 7.9 M (-0.03 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.07 | 1,789 | 10,859 | 7,949,966 | 8 M to 7.9 M (-0.02 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.06 | 4,231 | 25,640 | 7,951,755 | 8 M to 8 M (-0.05 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.05 | 9,006 | 54,486 | 7,955,986 | 8 M to 8 M (-0.11 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.04 | 2,665 | 16,097 | 7,964,992 | 8 M to 8 M (-0.03 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.03 | 10,759 | 64,877 | 7,967,657 | 8 M to 8 M (-0.13 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.02 | 2,132 | 12,835 | 7,978,416 | 8 M to 8 M (-0.03 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.40 | 3,400 | 21,760 | 7,980,548 | 8 M to 8 M (-0.04 %) |
Aug 26 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.37 | 1,100 | 7,007 | 7,983,948 | 8 M to 8 M (-0.01 %) |
Aug 21 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.10 | 2,100 | 12,810 | 8,516,913 | 8.5 M to 8.5 M (-0.02 %) |
Aug 21 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.09 | 12,200 | 74,298 | 8,519,013 | 8.5 M to 8.5 M (-0.14 %) |
Aug 21 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.08 | 700 | 4,256 | 8,531,213 | 8.5 M to 8.5 M (-0.01 %) |
Aug 21 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.15 | 6,182 | 38,019 | 8,531,913 | 8.5 M to 8.5 M (-0.07 %) |
Aug 21 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.14 | 4,280 | 26,279 | 8,538,095 | 8.5 M to 8.5 M (-0.05 %) |
Aug 21 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.12 | 91 | 557 | 8,542,375 | 8.5 M to 8.5 M (0.00 %) |
Aug 21 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.11 | 2,859 | 17,468 | 8,542,466 | 8.5 M to 8.5 M (-0.03 %) |
Aug 21 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.10 | 46,031 | 280,789 | 8,545,325 | 8.6 M to 8.5 M (-0.54 %) |
Aug 21 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.09 | 4,550 | 27,710 | 8,591,356 | 8.6 M to 8.6 M (-0.05 %) |
Aug 21 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.08 | 728 | 4,426 | 8,595,906 | 8.6 M to 8.6 M (-0.01 %) |
Aug 21 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.07 | 31,821 | 193,153 | 8,596,634 | 8.6 M to 8.6 M (-0.37 %) |
Aug 21 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.05 | 3,458 | 20,921 | 8,628,455 | 8.6 M to 8.6 M (-0.04 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.15 | 3,684 | 22,657 | 8,631,913 | 8.6 M to 8.6 M (-0.04 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.14 | 12,828 | 78,764 | 8,635,597 | 8.6 M to 8.6 M (-0.15 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.13 | 23,344 | 143,099 | 8,648,425 | 8.7 M to 8.6 M (-0.27 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.12 | 10,688 | 65,411 | 8,671,769 | 8.7 M to 8.7 M (-0.12 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.11 | 3,047 | 18,617 | 8,682,457 | 8.7 M to 8.7 M (-0.04 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.10 | 46,409 | 283,095 | 8,685,504 | 8.7 M to 8.7 M (-0.53 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.40 | 2,730 | 17,472 | 8,731,913 | 8.7 M to 8.7 M (-0.03 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.35 | 182 | 1,156 | 8,734,643 | 8.7 M to 8.7 M (0.00 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.30 | 1,274 | 8,026 | 8,734,825 | 8.7 M to 8.7 M (-0.01 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.25 | 4,551 | 28,444 | 8,736,099 | 8.7 M to 8.7 M (-0.05 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.23 | 2,275 | 14,173 | 8,740,650 | 8.7 M to 8.7 M (-0.03 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.18 | 1,571 | 9,709 | 8,742,925 | 8.7 M to 8.7 M (-0.02 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.14 | 1,001 | 6,146 | 8,744,496 | 8.7 M to 8.7 M (-0.01 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.13 | 1,477 | 9,054 | 8,745,497 | 8.7 M to 8.7 M (-0.02 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.12 | 2,093 | 12,809 | 8,746,974 | 8.7 M to 8.7 M (-0.02 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.11 | 4,349 | 26,572 | 8,749,067 | 8.8 M to 8.7 M (-0.05 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.10 | 9,187 | 56,041 | 8,753,416 | 8.8 M to 8.8 M (-0.10 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.09 | 455 | 2,771 | 8,762,603 | 8.8 M to 8.8 M (-0.01 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.08 | 1,530 | 9,302 | 8,763,058 | 8.8 M to 8.8 M (-0.02 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.07 | 4,638 | 28,153 | 8,764,588 | 8.8 M to 8.8 M (-0.05 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.05 | 728 | 4,404 | 8,769,226 | 8.8 M to 8.8 M (-0.01 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.04 | 7,730 | 46,689 | 8,769,954 | 8.8 M to 8.8 M (-0.09 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.03 | 3,227 | 19,459 | 8,777,684 | 8.8 M to 8.8 M (-0.04 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.02 | 3,046 | 18,337 | 8,780,911 | 8.8 M to 8.8 M (-0.03 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.01 | 11,249 | 67,606 | 8,783,957 | 8.8 M to 8.8 M (-0.13 %) |
Aug 19 2009 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Sell | S | 6.00 | 13,696 | 82,176 | 8,795,206 | 8.8 M to 8.8 M (-0.16 %) |